Tumour necrosis factor-α production during cytomegalovirus infection in immunosuppressed rats
暂无分享,去创建一个
Bart L. Haagmans | Marian C. Horzinek | B. Haagmans | E. Claassen | A. Eertwegh | V. Schijns | E. Claassen | A. J. van den Eertwegh | V. E. C. J. Schijns
[1] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[2] Jiahuai Han,et al. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2] , 1990, The Journal of experimental medicine.
[3] J. Shanley,et al. IS CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS IN TRANSPLANT RECIPIENTS AN IMMUNOPATHOLOGICAL CONDITION? , 1987, The Lancet.
[4] P. Vassalli,et al. The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.
[5] R. Chanock,et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Goeddel,et al. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. , 1986, Nature.
[7] Marian C. Horzinek,et al. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus , 1994, Journal of virology.
[8] C. Dinarello. Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.
[9] E. Claassen,et al. In vivo kinetics and characterization of IFN-gamma-producing cells during a thymus-independent immune response. , 1991, Journal of immunology.
[10] L. F. Fajardo,et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.
[11] M. Raffeld,et al. Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. , 1992, The Journal of clinical investigation.
[12] D. Hallahan,et al. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Moore,et al. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[14] Marian C. Horzinek,et al. Tumour necrosis factor α, interferon γ and interferon β exert antiviral activity in nervous tissue cells , 1991 .
[15] L. Aarden,et al. Functional discrimination between interleukin 6 and interleukin 1 , 1988, European journal of immunology.
[16] J. Snick,et al. Interleukin-6: an overview. , 1990, Annual review of immunology.
[17] D. Longo,et al. Death in the AIDS patient: role of cytomegalovirus. , 1983, The New England journal of medicine.
[18] R. Schreiber,et al. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. , 1989, Journal of immunology.
[19] M. Ho,et al. Cytomegalovirus: Biology and Infection , 1982 .
[20] B. Beutler,et al. CACHECTIN: MORE THAN A TUMOR NECROSIS FACTOR , 1988 .
[21] A. Billiau. Redefining interferon: the interferon-like antiviral effects of certain cytokines (interleukin-1, interferon-beta 2, interferon-gamma) may be indirect or side effects. , 1987, Antiviral research.
[22] H. Holtmann,et al. Tumor necrosis factor induction by Sendai virus. , 1986, Journal of immunology.
[23] M. Ho. Human Cytomegalovirus Infections in Immunosuppressed Patients , 1991 .
[24] N. Flournoy,et al. Risk factors for cytomegalovirus infection after human marrow transplantation. , 1986, The Journal of infectious diseases.
[25] H. Tilg,et al. Cachexia and tumour necrosis factor-alpha in cytomegalovirus infection. , 1991, Journal of clinical pathology.
[26] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[27] H. Romijn,et al. Culture of rat cerebral oligodendrocytes in a serum-free, chemically defined medium , 1984, Journal of Neuroscience Methods.
[28] E. Huang,et al. Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. , 1989, Journal of immunology.
[29] C. Herzog,et al. [Interleukin 1 and tumor necrosis factor]. , 1987, Zeitschrift fur Rheumatologie.
[30] L. Cone,et al. Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. , 1986, AIDS research.